Qualcomm Incorporated (NASDAQ: QCOM) today announced that its Board of Directors has approved an increase in the Company’s quarterly cash dividend from $0.85 to $0.89 per share of common stock. This ...

Elon Musk is looking to expand Neuralink applications to telepathy and telekinesis The Tesla and X CEO brain implant venture, ...

Worksport Ltd. holds more than 170 registered and pending patents and trademarks, maintains $6 million cash on hand (as of March 3, 2025), and carries minimal debt (Debt-to-Asset Ratio of 0.32 as of ...

Jane Møller Nielsen explains why a love for linguistics can help build a successful IP career, and reveals the Pippi ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Fast Company's 2025 list of the most innovative companies in beauty includes L'Oréal, Vacation, Megababe, E.l.f. Beauty, and ...

Expert testimony plays a critical role in Patent Trial and Appeal Board (PTAB) proceedings at the U.S. Patent and Trademark Office (USPTO).

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

Hammes, a national real estate consulting, development, investment and management firm, is proud to announce that its Operational Readiness Executives, Terri Palazzo and Katherine Kay Brown, will ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expect ...

A recent online survey by Leger, commissioned by Eisai Limited (Canada), reveals alarming statistics about our sleep in Canada. Over half (54%) of Canadians report difficulty falling or staying asleep ...